Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Rasonque (daraxonrasib)FDA approves Rasonque (daraxonrasib)26 August 2026The FDA approved Rasonque (daraxonrasib), a drug from Revolution Medicines. Form: Tablet, Oral. Granted priority review, reserved for treatments that would be a significant improvement over what exists. Application NDA220910.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)